CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 7, 2023 · earnings

ACRS earnings: a negative outcome, -7.2%

On August 7, 2023, Aclaris Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.2% in the window around the event.

The move

$9.85
1d before
$9.14
Event day
$8.66
1d after
$8.22
5d after

Pre-catalyst setup

-3.9%
30-day run-up
3380%
30-day volatility
1.9×
volume spike